Symbol: |
ASB5
|
Description: |
ankyrin repeat and SOCS box containing 5 [Source:HGNC Symbol;Acc:17180]
|
Location: |
Chr4:177134824-177198722[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:97
Gene |
Compound |
Gen_sig |
Exp_pattern |
ASB5 |
CYCLOMETHYLENOMYCIN A |
0.044 |
Down |
ASB5 |
3-Phenacyliden-5-brom-2-indolinon |
0.026 |
Down |
ASB5 |
Cycloalkannin |
0.046 |
Down |
ASB5 |
CAP 1 hydrochloride |
0.049 |
Down |
ASB5 |
NSC 351351 |
0.036 |
Down |
ASB5 |
11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride |
0.028 |
Down |
ASB5 |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.02 |
Down |
ASB5 |
NSC 6246 |
0.049 |
Up |
ASB5 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride |
0.025 |
Down |
ASB5 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.036 |
Down |
ASB5 |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.011 |
Up |
ASB5 |
NSC 650958 |
0.042 |
Down |
ASB5 |
NSC 65683 |
0.009 |
Up |
ASB5 |
NSC 666112 |
0.025 |
Down |
ASB5 |
N,N-bis(2-chloropropyl)-N-methylammonium chloride |
0.048 |
Down |
Expression pattern: Sensitivity / Resistance
Total:7 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:26
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:6
Gene |
Gen_transcript |
miRNA |
miR_location |
ASB5 |
ENST00000296525 |
hsa-mir-144-5p |
Chr17:27188601-27188622[-] |
ASB5 |
ENST00000296525 |
hsa-mir-183-3p |
Chr7:129414768-129414789[-] |
ASB5 |
ENST00000296525 |
hsa-mir-29b-2-5p |
Chr1:207975837-207975858[-] |
ASB5 |
ENST00000296525 |
hsa-mir-32-5p |
Chr9:111808552-111808573[-] |
ASB5 |
ENST00000296525 |
hsa-mir-553 |
Chr1:100746812-100746832[+] |
ASB5 |
ENST00000296525 |
hsa-mir-649 |
Chr22:21388480-21388501[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|